Jake E. Delmore

4.6k citations
35 papers · 3.9k · 1 hit paper · h-index 20

Impact in

  • Hematology top 1%
    • Multiple Myeloma Research and Treatments
    • Protein Degradation and Inhibitors
    • Ubiquitin and proteasome pathways
    • Histone Deacetylase Inhibitors Research
    • Epigenetics and DNA Methylation
    • Metabolism, Diabetes, and Cancer
    • Genomics and Chromatin Dynamics

Papers in

    • Multiple Myeloma Research and Treatments 15
    • Protein Degradation and Inhibitors 6
    • Metabolism, Diabetes, and Cancer 6
    • PI3K/AKT/mTOR signaling in cancer 5
    • Ubiquitin and proteasome pathways 4

Jake E. Delmore

35 papers receiving 3.8k citations

Jake E. Delmore's Hit Papers

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc 2011 · 2.4k citations
2.4k0+5+10Years since publication50010001.5k2.0k

Peers

Jake E. Delmore
Comparison fields: 5 of 90
  • Hematology 1.0k
  • Molecular Biology 3.0k
  • Oncology 819
  • Cancer Research 248
  • Genetics 137
Replace Hiroya Asou with:
Hiroya Asou Japan
Fausto Grignani Italy
Manik Chatterjee Germany
Leonie A. Cluse Australia
Sally A. Przybranowski United States
Bing Z. Carter United States
Diana D. Cirstea United States
Rémy Castellano France
Olena Barbash United States
Evelyn Mary McKeegan United States
Jake E. Delmore relative to Hiroya Asou Japan Hiroya Asou's profile →
Citations per field
00.5×2×3×4.2×
Hiroya Asou · 1×
Citations per year

Countries citing papers authored by Jake E. Delmore

Since Specialization
Citations

This map shows the geographic impact of Jake E. Delmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake E. Delmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake E. Delmore more than expected).

Fields of papers citing papers by Jake E. Delmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jake E. Delmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake E. Delmore. The network helps show where Jake E. Delmore may publish in the future.

Co-authors

The 25 scholars most cited alongside Jake E. Delmore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jake E. Delmore Line = papers co-authored together Jake E. Delmore links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Hit paper breakdown →
20112412
2 2010267
3 2017232
4 2011139
5 2018134
6 2009110
7 201169
8 201360
9
Mixed germ cell malignancy of the ovary concurrent with pregnancy.
199455
10 201249
11 201239
12 201230
13 201230
14 201028
15 201127
16 200926
17 202325
18 200724
19 201124
20
Parameters of differentiation and proliferation in adult granulosa cell tumors of the ovary.
200123

About Jake E. Delmore

Jake E. Delmore is a scholar working on Hematology, Molecular Biology, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 35 papers that have together received 3.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (6 papers), Metabolism, Diabetes, and Cancer (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Mechanisms and Therapy (4 papers), Ubiquitin and proteasome pathways (4 papers), Microtubule and mitosis dynamics (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Hematology (1.0k citations), Molecular Biology (3.0k citations), Oncology (819 citations), Cancer Research (248 citations) and Genetics (137 citations). Jake E. Delmore has collaborated with scholars based in United States, Switzerland and Slovakia. Frequent co-authors include Constantine S. Mitsiades, Paul Gerard Guy Richardson, Douglas W. McMillin, Kenneth Carl Anderson, Steffen Klippel, Joseph M. Negri, Melissa Gaik Ming Ooi, Nikhil C. Munshi, Nicholas Mitsiades and Robert L Schlossman. Their work appears in journals such as Blood, British Journal of Haematology, The Journal of Clinical Endocrinology & Metabolism, Nature Medicine and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact